NDLI: Use of statin medications and risk of esophageal adenocarcinoma in persons with Barrett's esophagus.

Please wait, while we are loading the content...

Tumor suppressor function of PGP9.5 is associated with epigenetic regulation in prostate cancer--novel predictor of biochemical recurrence after radical surgery.

Associations between genes in the one-carbon metabolism pathway and advanced colorectal adenoma risk in individuals with low folate intake.

Vitamin D and calcium supplementation and one-year change in mammographic density in the women's health initiative calcium and vitamin D trial.

Common variation in Nemo-like kinase is associated with risk of ovarian cancer.

Nitrosamines and heme iron and risk of prostate cancer in the European prospective investigation into cancer and nutrition.

Vasoactive peptides with angiogenesis-regulating activity predict cancer risk in males.

Telomere length and genetic variation in telomere maintenance genes in relation to ovarian cancer risk.

Gene set analysis of survival following ovarian cancer implicates macrolide binding and intracellular signaling genes.

The United States Preventive Services Task Force recommendation against prostate-specific antigen screening--point.

The United States Preventive Services Task Force recommendation against prostate-specific antigen screening--counterpoint.

Milk and dairy consumption among men with prostate cancer and risk of metastases and prostate cancer death.

Long-term psychosocial outcomes of BRCA1/BRCA2 testing: differences across affected status and risk-reducing surgery choice.

Light exposure and melatonin among rotating shift nurses--letter.

Year: 2012 Volume: 21 Issue: 2

Year: 2012 Volume: 21 Issue: 1

Year: 2011 Volume: 20

Year: 2010 Volume: 19

Year: 2009 Volume: 18

Year: 2008 Volume: 17

Year: 2007 Volume: 16

Year: 2006 Volume: 15

Year: 2005 Volume: 14

Year: 2004 Volume: 13

Year: 2003 Volume: 12

Use of statin medications and risk of esophageal adenocarcinoma in persons with Barrett's esophagus.

Content Provider	World Health Organization (WHO)-Global Index Medicus
Author	Kantor, Elizabeth D. Onstad, Lynn Blount, Patricia L. Reid, Brian J. Vaughan, Thomas L.
Description	Country affiliation: United States Author Affiliation: Kantor ED ( Public Health Sciences, FredHutchinson Cancer Research Center)
Abstract	BACKGROUND: Persons with Barrett's esophagus experience increased incidence of esophageal adenocarcinoma and may benefit from use of preventives. Studies suggest that statin medications may have chemopreventive properties; we therefore assessed the association between statin use and progression to esophageal adenocarcinoma. METHODS: In a prospective cohort of 411 persons with Barrett's, Cox regression was used to calculate HRs for nonsteroidal anti-inflammatory drug (NSAID) and statin use accounting for variation in use during follow-up and adjusting for age, sex, and smoking. RESULTS: The HRs for statin use among all participants were 0.59 [95% confidence interval (CI), 0.26-1.33] and 0.68 (95% CI, 0.30-1.54) before and after further adjustment for NSAID use, respectively. Among persons with high-grade dysplasia, the HRs for statin use were 0.31 (95% CI, 0.11-0.86) and 0.41 (95% CI, 0.13-1.26) before and after adding NSAIDs to the model, respectively. CONCLUSIONS: While the reduced risk of esophageal adenocarcinoma observed among statin users may be explained by chance, the point estimates are similar in magnitude to those previously reported for NSAID use in this cohort and are unlikely to be confounded by known risk factors. IMPACT: Further study in larger cohorts and meta-analyses of the potential for statins to reduce risk of esophageal adenocarcinoma is warranted.
File Format	HTM / HTML
ISSN	10559965
e-ISSN	15387755
DOI	10.1158/1055-9965.EPI-11-1014
Journal	Cancer Epidemiology Biomarkers & Prevention
Issue Number	3
Volume Number	21
Language	English
Publisher	American Association for Cancer Research
Publisher Date	2012-03-01
Publisher Place	United States
Access Restriction	Open
Subject Keyword	Discipline Cancer epidemiology Adenocarcinoma Chemically Induced Anti-inflammatory Agents, Non-steroidal Adverse Effects Barrett Esophagus Drug Therapy Esophageal Neoplasms Hydroxymethylglutaryl-coa Reductase Inhibitors Disease Progression Prognosis Prospective Studies Risk Factors Research Support, N.i.h., Extramural
Content Type	Text
Resource Type	Article
Subject	Epidemiology Oncology

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Statins and aspirin for chemoprevention in Barrett's esophagus: results of a cost-effectiveness analysis.

Tissue and serum mesothelin are potential markers of neoplastic progression in Barrett's associated esophageal adenocarcinoma.

Statin use and risk of prostate cancer in the prospective Osteoporotic Fractures in Men (MrOS) Study.

Meat consumption and the risk of Barrett's esophagus in a large Dutch cohort.

Barrett's oesophagus: frequency and prediction of dysplasia and cancer.

Inflammation and oxidative stress markers and esophageal adenocarcinoma incidence in a Barrett's esophagus cohort.

Variation in age at cancer diagnosis in familial versus nonfamilial Barrett's esophagus.

Lipophilic statin use and risk of breast cancer subtypes.

Importance of a multidisciplinary approach for the treatment of Barrett's esophagus.

Use of statin medications and risk of esophageal adenocarcinoma in persons with Barrett's esophagus.

Similar Documents

Statins and aspirin for chemoprevention in Barrett's esophagus: results of a cost-effectiveness analysis.

Tissue and serum mesothelin are potential markers of neoplastic progression in Barrett's associated esophageal adenocarcinoma.

Statin use and risk of prostate cancer in the prospective Osteoporotic Fractures in Men (MrOS) Study.

Meat consumption and the risk of Barrett's esophagus in a large Dutch cohort.

Barrett's oesophagus: frequency and prediction of dysplasia and cancer.

Inflammation and oxidative stress markers and esophageal adenocarcinoma incidence in a Barrett's esophagus cohort.

Variation in age at cancer diagnosis in familial versus nonfamilial Barrett's esophagus.

Lipophilic statin use and risk of breast cancer subtypes.

Importance of a multidisciplinary approach for the treatment of Barrett's esophagus.

Use of statin medications and risk of esophageal adenocarcinoma in persons with Barrett's esophagus.